Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Disease Models & Mechanisms
|
December 3, 2008
The clinician-scientist: a rare breed under threat in a hostile environment
Nick R Lemoine
Best Practice & Research. Clinical Gastroenterology
|
March 22, 2006
Gene therapy developments for pancreatic cancer
Madhumita Bhattacharyya, Nick R Lemoine
Current Opinion in Molecular Therapeutics
|
January 15, 2010
Combination of anti-angiogenic therapy and virotherapy: arming oncolytic viruses with anti-angiogenic genes
James R Tysome, Nick R Lemoine, Yaohe Wang
Oncotargets and Therapy
|
August 14, 2013
Update on oncolytic viral therapy - targeting angiogenesis
James R Tysome, Nick R Lemoine, Yaohe Wang
The Lancet. Oncology
|
March 22, 2002
Oncolytic biotherapy: a novel therapeutic plafform
Lynda K Hawkins, Nick R Lemoine, David Kirn
Nature Clinical Practice. Oncology
|
August 4, 2005
Mechanisms of disease: the impact of antithrombotic therapy in cancer patients
Gloria A Petralia, Nick R Lemoine, Ajay K Kakkar
The Journal of Pathology
|
December 20, 2005
Bacterial gene therapy strategies
Georges Vassaux, Josianne Nitcheu, Sarah Jezzard, et al.
Oncotarget
|
February 13, 2016
The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11
Constantia Pantelidou, Gioia Cherubini, Nick R Lemoine, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 28, 2002
RT-PCR from laser-capture microdissected samples
Tatjana Crnogorac-Jurcevic, Torsten O Nielsen, Nick R Lemoine
International Journal of Cancer
|
February 22, 2007
Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy
Rita Bayer Lopes, Rathi Gangeswaran, Iain A McNeish, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Disease Models & Mechanisms
|
December 3, 2008
The clinician-scientist: a rare breed under threat in a hostile environment
Nick R Lemoine
Best Practice & Research. Clinical Gastroenterology
|
March 22, 2006
Gene therapy developments for pancreatic cancer
Madhumita Bhattacharyya, Nick R Lemoine
Current Opinion in Molecular Therapeutics
|
January 15, 2010
Combination of anti-angiogenic therapy and virotherapy: arming oncolytic viruses with anti-angiogenic genes
James R Tysome, Nick R Lemoine, Yaohe Wang
Oncotargets and Therapy
|
August 14, 2013
Update on oncolytic viral therapy - targeting angiogenesis
James R Tysome, Nick R Lemoine, Yaohe Wang
The Lancet. Oncology
|
March 22, 2002
Oncolytic biotherapy: a novel therapeutic plafform
Lynda K Hawkins, Nick R Lemoine, David Kirn
Nature Clinical Practice. Oncology
|
August 4, 2005
Mechanisms of disease: the impact of antithrombotic therapy in cancer patients
Gloria A Petralia, Nick R Lemoine, Ajay K Kakkar
The Journal of Pathology
|
December 20, 2005
Bacterial gene therapy strategies
Georges Vassaux, Josianne Nitcheu, Sarah Jezzard, et al.
Oncotarget
|
February 13, 2016
The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11
Constantia Pantelidou, Gioia Cherubini, Nick R Lemoine, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 28, 2002
RT-PCR from laser-capture microdissected samples
Tatjana Crnogorac-Jurcevic, Torsten O Nielsen, Nick R Lemoine
International Journal of Cancer
|
February 22, 2007
Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy
Rita Bayer Lopes, Rathi Gangeswaran, Iain A McNeish, et al.
Page
of 4